COVID-19 Pandemic Associated with Acute Stress, Depressive Symptoms in Residents of the United States
While the COVID-19 pandemic is a stress-inducing event, published empirical studies about mental health consequences are rare.
While the COVID-19 pandemic is a stress-inducing event, published empirical studies about mental health consequences are rare.
Continued use of glucocorticoids was associated with dose-dependent increase in the risk for serious infection, with small but significant risk for infection at low doses of 5 mg or less per day.
Remdesivir was immediately discontinued in both patients and a continuous infusion of acetylcysteine was initiated.
Therapies for the treatment of inflammatory bowel disease may have a potential use in patients with COVID-19.
The COVID-19 pandemic and the policies to contain it are pervasive, but the effects on depression symptoms are largely unknown.
The current COVID-19 pandemic requires rethinking some procedural protocols in ophthalmology practice.
These generic treatments have similar safety profiles to their reference products.
Researchers developed a microsimulation model of the natural history of injection opioid use to assess long-term infective endocarditis mortality associated with injection opioid use in the United States.
Researchers conducted a Phase 1/2 placebo-controlled trial to study the safety and immunogenicity of GBS conjugate vaccination.
The presence of a brain-eating amoeba in its drinking water has led the city of Lake Jackson, Texas, to issue a “do not use water order” and request an emergency declaration from the state.